Monday, October 12, 2026

EUR/CHF Bearish Momentum With A 1% Fall In The Last 10 Sessions

ViaNews Editorial Team

August 30, 2024

EUR/CHF Bearish Momentum With A 1% Fall In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.7% for the last 10 sessions. At 14:06 EST on Friday, 30 August, EUR/CHF (EURCHF) is $0.94.

EUR/CHF's yearly highs and lows, it's 4.075% up from its 52-week low and 5.358% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.19%, a negative 0.09%, and a positive 0.31%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.32% (last week), 0.39% (last month), and 0.31% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Thursday, 29 August, "Their effect on USD/JPY only became sustainable when they were accompanied by idiosyncratic USD weakness and, in particular, when it became foreseeable that the BoJ's monetary policy would turn.", "A credible USD/JPY ceiling affects USD/PY prices well below this ceiling and that USD/JPY does not even come close to this ceiling. "
  • According to FXStreet on Wednesday, 28 August, "In terms of resistance, the USD/JPY pair may challenge the immediate barrier at the nine-day Exponential Moving Average (EMA) around the 145.23 level. ", "On the downside, if the USD/JPY pair stays below the downtrend line, it could hover around the seven-month low of 141.69, recorded on August 5. "
  • Usd/jpy price forecast: post modest gains yet remains shy of 145.00. According to FXStreet on Thursday, 29 August, "The USD/JPY registered modest gains during the North American session on Thursday of over 0.27%. ", "If USD/JPY decisively clears 145.00, this could pave the way for further upside. "
  • Usd/jpy price forecast:  climbs amid strong US dollar, eyes 145.00. According to FXStreet on Wednesday, 28 August, "The USD/JPY reverses its course and registers decent gains of over 0.50% on Wednesday as the Greenback gains some steam, yet it remains vulnerable to the release of crucial data over the remainder of the week. ", "The USD/JPY downtrend remains intact, yet buyers stepped in and pushed the exchange rate above 144.00, with buyers unable to crack the 145.00 figure decisively. "
  • According to FXStreet on Friday, 30 August, "The downside for the USD/JPY pair may be capped, as the US Dollar maintains its recent gains following stronger-than-expected economic data released on Thursday. ", "Regarding resistance, the USD/JPY pair may test the immediate barrier at the nine-day Exponential Moving Average (EMA) around 145.15. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com